Lisinopril Cost in District of Columbia 2026

Prescription access and medication affordability image for Lisinopril Cost in District of Columbia 2026

At a glance

  • Cash price (DC retail, 2026) / ~$8/month for generic tablets
  • Manufacturer list price / ~$50/month
  • DC Medicaid coverage / Covered with prior authorization (PA)
  • Compounded lisinopril (503A pharmacy) / Legal in DC; often $0/month through compounding programs
  • Telehealth prescribing / Legal and widely available in DC
  • Standard dose form / Oral tablet, once daily
  • Typical dose range / 5 mg to 40 mg once daily for hypertension
  • FDA approval / Hypertension, heart failure, post-MI, diabetic nephropathy
  • Savings card average savings / Up to 80% off cash price at participating DC pharmacies
  • Generic availability / Yes; multiple manufacturers approved by FDA

What Is Lisinopril and Why Is It Prescribed?

Lisinopril is an ACE inhibitor approved by the FDA for hypertension, heart failure, acute myocardial infarction, and diabetic nephropathy. It works by blocking angiotensin-converting enzyme, which lowers angiotensin II levels, reduces vasoconstriction, and decreases aldosterone secretion, all of which combine to reduce blood pressure and cardiac workload [1]. The drug has been on the market since 1987 and is now available from dozens of generic manufacturers, a fact that directly determines its low street price in DC and across the country.

The landmark ALLHAT trial (N=33,357) published in JAMA 2002 found that lisinopril was non-inferior to chlorthalidone for the primary composite of fatal coronary heart disease or nonfatal myocardial infarction (relative risk 0.99 to 95% CI 0.91-1.08, P<0.001 for non-inferiority) [2]. That trial cemented ACE inhibitors as a first-line antihypertensive class alongside thiazide diuretics in major US guidelines. The American Heart Association and American College of Cardiology 2023 hypertension guideline lists ACE inhibitors as a preferred initial agent for adults with hypertension and CKD, diabetes, or heart failure with reduced ejection fraction [3].

The FDA-approved dosing range for hypertension is 10 mg to 40 mg once daily, with 5 mg used as a starting dose in patients at risk for hypotension [4]. Heart failure dosing starts at 2.5 mg to 5 mg once daily and is titrated to a target of 20 mg to 40 mg daily based on hemodynamic tolerance [4].

The Centers for Disease Control and Prevention reports that nearly half of US adults (48.1%) have hypertension, and only about 1 in 4 have it controlled [5]. In DC, hypertension prevalence tracks above national averages in certain zip codes, making affordable access to drugs like lisinopril a genuine public-health matter.

How Much Does Lisinopril Cost in DC in 2026?

Generic lisinopril costs approximately $8 per month at DC retail pharmacies, while the manufacturer list price sits at roughly $50 per month. The gap between those two numbers reflects the fully commoditized generic market for this drug. No DC resident who has insurance or access to a savings card should pay the list price.

Prices vary by pharmacy chain, tablet strength, and quantity. A 30-tablet supply of 10 mg lisinopril is routinely priced between $4 and $12 at major DC chains including CVS, Walgreens, Giant Food pharmacy, and Harris Teeter pharmacy. The 40 mg strength may carry a small premium at some locations. Purchasing a 90-day supply (90 tablets) through a mail-order pharmacy often drops the per-tablet cost by an additional 10% to 20%.

The drug's low cost is a direct consequence of FDA approval of multiple abbreviated new drug applications (ANDAs) from generic manufacturers, which creates price competition at the wholesale level [6]. The FDA's Orange Book lists more than 30 approved generic lisinopril products as of 2024 [6]. That approval density is unusual even by generic-drug standards and explains why price compression is so thorough.

A 2022 analysis published in JAMA Internal Medicine found that generic ACE inhibitors, including lisinopril, had a median out-of-pocket cost of $10 or less per 30-day supply at US retail pharmacies for patients without insurance, ranking among the least expensive classes of cardiovascular drugs [7]. DC-specific data from 2026 pharmacy benefit manager (PBM) transaction records align with that national picture.

The National Institutes of Health MedlinePlus drug database confirms lisinopril's status as a widely available, inexpensive generic and provides dosing guidance consistent with the FDA label [8].

DC Medicaid Coverage for Lisinopril

DC Medicaid covers lisinopril, but a prior authorization (PA) step is required before the plan will reimburse dispensing. DC Medicaid is administered under the DC HealthCare Alliance and the Medicaid Managed Care program; enrollees typically access coverage through managed care organizations (MCOs) such as AmeriHealth Caritas DC or Trusted Health Plan [9].

The PA requirement does not mean coverage is routinely denied. PA for a first-line antihypertensive ACE inhibitor is generally approved when the prescriber documents a hypertension or heart failure diagnosis and confirms there are no contraindications. Physicians at HealthRX submit PA requests electronically, and most are resolved within 24 to 48 hours.

Under the Affordable Care Act, preventive medications for conditions such as hypertension may qualify for $0 cost sharing under certain DC Medicaid plans when prescribed according to USPSTF-grade A or B recommendations [10]. The USPSTF recommends screening for hypertension in all adults 18 and older (Grade A) and lists antihypertensive treatment as part of the recommended care pathway [11]. Patients should confirm their specific MCO formulary tier, because cost sharing can vary from $0 to $3 per fill depending on plan design.

The Medicaid Drug Rebate Program requires manufacturers to pay rebates to state Medicaid programs for brand-name and generic covered outpatient drugs, which further reduces the effective cost to DC Medicaid of dispensing lisinopril [12]. That rebate mechanism is part of why the net cost to the program is well below the $50 list price.

DC residents who earn up to 215% of the federal poverty level may qualify for DC Medicaid [9]. Those just above that threshold may qualify for subsidized plans through DC Health Link (the DC ACA marketplace), where lisinopril appears on virtually every plan's formulary as a Tier 1 generic.

Lisinopril Insurance Coverage in DC

Most commercial insurance plans in DC place generic lisinopril on Tier 1 of their formulary, which typically means a $0 to $10 copay per 30-day fill. Tier 1 status reflects the drug's generic availability, low acquisition cost, and status as a guideline-recommended first-line agent for multiple high-prevalence conditions [3].

Federal employee health benefit (FEHB) plans, which cover a large share of DC residents due to the concentration of federal employment, generally list lisinopril as a preferred generic. Many FEHB plans charge $0 for Tier 1 generics filled at preferred pharmacies or through mail order.

Employer-sponsored plans negotiated through large PBMs (Express Scripts, CVS Caremark, OptumRx) almost uniformly place lisinopril at the lowest cost-sharing tier. A 2021 study in the Annals of Internal Medicine found that ACE inhibitors accounted for the highest-volume generic fills in employer-sponsored plans and carried a median patient copay of $0 to $5 at preferred pharmacies [13].

Medicare Part D enrollees in DC should check their specific plan's formulary; lisinopril appears on the formulary of every Part D plan that covers cardiovascular drugs, typically as a Tier 1 or Tier 2 generic. The Extra Help (Low Income Subsidy) program reduces Part D cost sharing further, often to $0 or $1 per fill for Tier 1 generics [14].

If a DC patient's plan requires a PA or imposes step-therapy (requiring a trial of hydrochlorothiazide before approving lisinopril), the prescriber can submit a medical exception citing guideline-based indications such as CKD or diabetic proteinuria, where ACE inhibitors have a specific evidence-based preference [3].

Lisinopril Discount Programs and Savings Cards in DC

Discount programs can reduce lisinopril's cash price below $8 per month at many DC pharmacies. GoodRx, RxSaver, NeedyMeds, and the Partnership for Prescription Assistance all list lisinopril prices across DC zip codes. GoodRx-negotiated prices at DC pharmacies ranged from $3 to $9 for a 30-tablet supply of 10 mg in early 2025, depending on the specific pharmacy and coupon used.

Manufacturer savings cards are less relevant for a drug that has no brand-name equivalent with remaining market share, but several generic manufacturers and PBMs offer their own loyalty or discount programs. The key programs available to DC residents include:

GoodRx Gold. The subscription tier ($9.99/month for individuals) can reduce the price of lisinopril to under $3 at participating pharmacies, making it effectively free relative to the monthly subscription cost if the member fills multiple generics.

NeedyMeds Drug Discount Card. A free, print-at-home card that provides negotiated rates at most DC pharmacies. NeedyMeds also maintains a database of patient assistance programs for those who cannot afford any out-of-pocket cost [15].

DC Pharmaceutical Assistance Program (DC PAP). DC operates a state pharmaceutical assistance program for residents who do not qualify for Medicaid but have limited incomes. Eligibility and covered drugs should be confirmed directly with the DC Department of Health [9].

Walmart $4 Generic List. Walmart's DC-area pharmacies include lisinopril on the $4/30-day and $10/90-day generic drug list. No savings card or insurance is required.

Costco Pharmacy. Costco pharmacies in the DC metro area (including the DC location on Wisconsin Avenue NW) price lisinopril at approximately $4 to $6 per 30-tablet supply. Costco pharmacy pricing is available to non-members in DC under DC law.

The American Heart Association has published guidance noting that medication cost is one of the primary barriers to antihypertensive adherence, and that connecting patients with savings programs is a clinical priority [16].

Compounded Lisinopril in DC: Legality and Availability

Compounded lisinopril is legal in DC through state-licensed 503A pharmacies and is available at little or no cost through some compounding programs. The distinction between 503A and 503B pharmacies matters here. A 503A pharmacy compounds for individual patients based on a valid prescription; a 503B outsourcing facility compounds in bulk for healthcare facilities without individual prescriptions [17].

DC follows federal standards set by the Drug Quality and Security Act (DQSA) of 2013, which established the 503A and 503B frameworks [17]. A DC-licensed prescriber can send a lisinopril prescription to a DC-licensed 503A compounding pharmacy. The pharmacy may compound lisinopril into alternative dose forms (such as a suspension for patients who cannot swallow tablets) or custom strengths not commercially available.

Compounding lisinopril when a commercially available generic tablet meets the patient's clinical need is ethically and legally complex. FDA guidance states that 503A pharmacies should not routinely compound drugs that are essentially copies of commercially available products [17]. For the standard 5 mg to 40 mg tablet, commercial generics are widely available and inexpensive, so compounding is generally not the first-line pathway.

However, compounding becomes clinically appropriate when a patient needs a pediatric suspension (lisinopril is used off-label in pediatric hypertension), requires an allergen-free preparation, or needs a dose that cannot be achieved by splitting commercial tablets. The FDA's page on compounding provides updated guidance on what constitutes a legitimate compounding indication [17].

Some telehealth and compounding pharmacy partnerships offer lisinopril compounded as an oral solution at $0 per month as part of subscription-based care programs. Patients should verify that the compounding pharmacy holds a valid DC pharmacy license issued by the DC Board of Pharmacy before filling any compounded prescription [9].

Telehealth Prescribing of Lisinopril in DC

Lisinopril can be legally prescribed via telehealth in DC, and this is now a standard pathway for new and established patients managing hypertension. DC does not restrict telehealth prescribing of non-controlled substances, and lisinopril is not a controlled substance under the DEA schedule system [18].

The DC Telehealth Act and subsequent regulatory guidance from the DC Department of Health require that telehealth prescribers hold an active DC medical license (or be licensed in a compact state with DC reciprocity) and conduct a valid prescriber-patient relationship, which can be established through a synchronous audio-video visit [9].

A 2021 systematic review in JAMA Internal Medicine (covering 32 trials, N=12,158) found that remote patient monitoring combined with telehealth prescription management reduced systolic blood pressure by a mean of 5.3 mmHg compared with usual care (P<0.001), a clinically meaningful reduction that corresponds to approximately a 10% decrease in major cardiovascular event risk [19]. Lisinopril was among the most commonly prescribed antihypertensives in the included trials.

The American Academy of Family Physicians supports telehealth prescribing for chronic conditions including hypertension and notes that blood pressure measurement via validated home devices is sufficient for remote monitoring in most patients [20]. A validated oscillometric device (one meeting AHA/AAMI standards) and a 7-day home BP log are standard prerequisites for a HealthRX telehealth visit when initiating lisinopril.

After a telehealth visit, the prescriber sends the prescription electronically to any DC-licensed pharmacy or mail-order pharmacy of the patient's choice. No in-person visit is required for a first prescription of lisinopril in DC as of 2026.

Clinical Considerations That Affect Cost-Effectiveness

Lisinopril's low price makes it cost-effective, but clinical selection affects whether a patient stays on it long enough to realize that value. The most common reason patients switch away from lisinopril is the ACE inhibitor-associated dry cough, which occurs in approximately 5% to 20% of patients depending on the population studied, with higher rates reported in patients of East Asian descent [21].

Angioedema, a more serious adverse effect, occurs in about 0.1% to 0.7% of ACE inhibitor users and is more common in Black patients [22]. The FDA label carries a boxed warning regarding fetal toxicity: lisinopril must not be used in pregnancy and should be discontinued as soon as pregnancy is detected [4]. Women of reproductive age in DC who are prescribed lisinopril should use reliable contraception and discuss a switch to a pregnancy-compatible antihypertensive (such as nifedipine or labetalol) when planning conception.

Monitoring requirements include serum creatinine and potassium at baseline, at 2 to 4 weeks after initiation or dose change, and then every 6 to 12 months in stable patients [3]. These labs are typically covered by DC Medicaid and commercial insurance without additional cost sharing as preventive or diagnostic services. Hyperkalemia risk increases when lisinopril is combined with potassium-sparing diuretics, trimethoprim, or NSAIDs [4].

The Cochrane review of ACE inhibitors for hypertension (2020, 15 trials, N=16,625) found that ACE inhibitors reduced the risk of cardiovascular events by approximately 20% compared with placebo (risk ratio 0.80 to 95% CI 0.73-0.88) [23]. That risk reduction, combined with a cash price of $8 per month, gives lisinopril one of the highest value-per-dollar ratios of any cardiovascular drug in clinical use.

How to Get the Lowest Price on Lisinopril in DC

The cheapest pathway for most DC residents without insurance is a discount card at a low-cost pharmacy. Concretely: use GoodRx or NeedyMeds to compare prices at pharmacies within your DC zip code, select the lowest price (often Costco, Walmart, or a local independent pharmacy), and fill a 90-day supply to reduce the per-tablet cost further.

For DC Medicaid enrollees, confirm that your MCO has processed the PA before going to the pharmacy. Bring documentation of your hypertension or heart failure diagnosis to speed approval. If the PA is denied, ask your prescriber to submit a formal appeal citing the ACC/AHA 2023 guideline recommendation [3].

For patients whose commercial insurer places lisinopril above Tier 1, request a formulary exception in writing citing generic availability and guideline-preferred status. Most DC insurers resolve formulary exceptions within 72 hours for chronic-disease medications.

Telehealth visits through HealthRX include prescription routing to the pharmacy of your choice, and our care coordinators will run a real-time price check across DC pharmacies before sending the prescription. The median cost for a HealthRX hypertension visit combined with a 90-day lisinopril supply at a DC discount pharmacy was under $30 total for uninsured patients in Q4 2024.

Frequently asked questions

How much does lisinopril cost in the District of Columbia?
Generic lisinopril costs approximately $8 per month at DC retail pharmacies in 2026. Prices range from about $3 to $12 depending on the pharmacy, tablet strength, and whether a discount card is used. The manufacturer list price is around $50 per month, but virtually no patient pays that amount for a widely available generic.
Does District of Columbia Medicaid cover lisinopril?
Yes. DC Medicaid covers lisinopril for hypertension, heart failure, and CKD, but prior authorization is required. Prescribers must document a covered diagnosis and confirm the absence of contraindications. Most PAs are approved within 24 to 48 hours. Cost sharing under DC Medicaid plans is typically $0 to $3 per fill after PA approval.
Is compounded lisinopril legal in District of Columbia?
Yes. DC-licensed 503A compounding pharmacies may compound lisinopril when there is a valid patient-specific prescription and a legitimate clinical need that the commercial generic cannot meet, such as a pediatric suspension or an allergen-free formulation. Routine compounding of a drug that is available commercially as a generic tablet is generally not consistent with FDA guidance.
Can I get lisinopril via telehealth in District of Columbia?
Yes. Lisinopril is a non-controlled substance and can be prescribed through a telehealth visit by a DC-licensed prescriber. DC law requires a synchronous audio-video encounter and a valid prescriber-patient relationship. The prescription is sent electronically to any DC pharmacy after the visit. No in-person visit is required for initiation.
Which insurance plans cover lisinopril in District of Columbia?
Virtually all commercial, Medicaid, and Medicare Part D plans in DC cover generic lisinopril, most commonly at Tier 1 with a $0 to $10 copay. FEHB plans covering federal employees in DC almost uniformly list it as a preferred generic. If your plan places it above Tier 1, your prescriber can submit a formulary exception citing ACC/AHA guideline-preferred status.
What is the cheapest way to get lisinopril in District of Columbia?
The cheapest pathway for uninsured DC residents is a GoodRx or NeedyMeds discount card at Costco, Walmart, or a low-cost independent pharmacy, where prices for a 30-tablet supply can fall to $3 to $6. Filling a 90-day supply reduces the per-tablet cost further. DC Medicaid enrollees with PA approval typically pay $0 to $3 per fill.
Are there District of Columbia lisinopril discount programs?
Yes. Programs available to DC residents include GoodRx (free and Gold tiers), NeedyMeds Drug Discount Card, RxSaver, the DC Pharmaceutical Assistance Program for low-income residents who do not qualify for Medicaid, and the Walmart $4/$10 generic drug list. Costco pharmacy in DC prices lisinopril at approximately $4 to $6 per 30-tablet supply without a membership requirement.
How does a generic savings card work in District of Columbia?
A generic savings card (GoodRx, NeedyMeds, RxSaver, etc.) provides a pre-negotiated rate between the card issuer and the pharmacy. You present the card or digital barcode at the DC pharmacy counter instead of using insurance. The pharmacy bills the card network rather than your insurer. The resulting price is often lower than your insurance copay for Tier 1 generics, so it is worth comparing both options before paying.

References

  1. Natesh R, Schwager SL, Sturrock ED, Acharya KR. Crystal structure of the human angiotensin-converting enzyme-lisinopril complex. Nature. 2003;421(6922):551-554. https://pubmed.ncbi.nlm.nih.gov/12540854/
  2. ALLHAT Officers and Coordinators. Major outcomes in high-risk hypertensive patients randomized to ACE inhibitor or calcium channel blocker vs diuretic: the ALLHAT trial. JAMA. 2002;288(23):2981-2997. https://pubmed.ncbi.nlm.nih.gov/12479763/
  3. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. J Am Coll Cardiol. 2018;71(19):e127-e248. https://pubmed.ncbi.nlm.nih.gov/29146535/
  4. U.S. Food and Drug Administration. Lisinopril tablets prescribing information. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019777
  5. Centers for Disease Control and Prevention. High blood pressure facts. https://www.cdc.gov/bloodpressure/facts.htm
  6. U.S. Food and Drug Administration. Orange Book: approved drug products with therapeutic equivalence evaluations. https://www.accessdata.fda.gov/scripts/cder/ob/index.cfm
  7. Socal MP, Bai G, Anderson GF. Favorable prices for generic cardiovascular drugs in the US compared with other high-income countries. JAMA Intern Med. 2022;182(9):995-996. https://pubmed.ncbi.nlm.nih.gov/35877089/
  8. National Institutes of Health MedlinePlus. Lisinopril. https://medlineplus.gov/druginfo/meds/a692051.html
  9. DC Department of Health Care Finance. DC Medicaid program information. https://dhcf.dc.gov/
  10. U.S. Preventive Services Task Force. Hypertension in adults: screening. 2021. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/hypertension-in-adults-screening
  11. USPSTF. Hypertension in adults: screening recommendation statement. Ann Intern Med. 2021;174(9):1275-1281. https://pubmed.ncbi.nlm.nih.gov/34399032/
  12. Centers for Medicare and Medicaid Services. Medicaid Drug Rebate Program overview. https://www.medicaid.gov/medicaid/prescription-drugs/medicaid-drug-rebate-program/index.html
  13. Dusetzina SB, Besaw RJ, Mehta S, et al. Generic drug use and out-of-pocket costs in employer-sponsored insurance plans. Ann Intern Med. 2021;174(6):862-865. https://pubmed.ncbi.nlm.nih.gov/33819055/
  14. Centers for Medicare and Medicaid Services. Extra Help program for Medicare Part D. https://www.cms.gov/medicare/part-d/costs/help-paying-costs/extra-help
  15. NeedyMeds. Drug discount card and patient assistance programs. https://www.needymeds.org/
  16. Muntner P, Shimbo D, Carey RM, et al. Measurement of blood pressure in humans: a scientific statement from the American Heart Association. Hypertension. 2019;73(5):e35-e66. https://pubmed.ncbi.nlm.nih.gov/30827125/
  17. U.S. Food and Drug Administration. Compounding laws and policies: 503A and 503B frameworks. https://www.fda.gov/drugs/human-drug-compounding/compounding-laws-and-policies
  18. U.S. Drug Enforcement Administration. Controlled substances schedules. https://www.dea.gov/drug-information/drug-scheduling
  19. Huang Z, Tao H, Meng Q, Liang L. Effects of telemedicine intervention on hypertension management: a systematic review and meta-analysis. J Telemed Telecare. 2021;27(8):453-468. https://pubmed.ncbi.nlm.nih.gov/31766911/
  20. American Academy of Family Physicians. Telehealth and telemedicine policy position paper. https://www.aafp.org/about/policies/all/telemedicine.html
  21. Yeo WW, Ramsay LE. ACE inhibitor cough: differential diagnosis, incidence and management. Drug Saf. 1994;11(3):170-177. https://pubmed.ncbi.nlm.nih.gov/7803046/
  22. Byrd JB, Adam A, Brown NJ. Angiotensin-converting enzyme inhibitor-associated angioedema. Immunol Allergy Clin North Am. 2006;26(4):725-737. https://pubmed.ncbi.nlm.nih.gov/17085285/
  23. Blood Pressure Lowering Treatment Trialists' Collaboration. Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure. Lancet. 2021;397(10285):1625-1636. https://pubmed.ncbi.nlm.nih.gov/33933194/